Log In
Print
BCIQ
Print
Print this Print this
 

dovitinib lactate (TKI258)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral multitargeted receptor tyrosine kinase inhibitor (TKI)
Molecular Target Fibroblast growth factor (FGF) receptor 1 (FGFR1) (CD331) ; Vascular endothelial growth factor (VEGF) receptor
Mechanism of ActionKinase inhibitor; Vascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today